Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis

Masataka Matsumoto, Sally Roufail, Rachael Inder, Carol Caesar, Tara Karnezis, Ramin Shayan, Rae Helen Farnsworth, Teruhiko Sato, Marc G Achen, Gregory B Mann, Steven A Stacker

Research output: Contribution to journalArticleResearchpeer-review

28 Citations (Scopus)

Abstract

Metastasis to regional lymph nodes is an important and early event in many tumors. Vascular endothelial growth factor-C (VEGF-C), VEGF-D and their receptor VEGFR-3, play a role in tumor spread via the lymphatics, although the timing of their involvement is not understood. In contrast, VEGFR-2, activated by VEGF-A, VEGF-C and VEGF-D, is a mediator of angiogenesis and drives primary tumor growth. We demonstrate the critical role for VEGFR-3, but not VEGFR-2, in the early events of metastasis. In a tumor model exhibiting both VEGF-D-dependent angiogenesis and lymphangiogenesis, an antibody to VEGFR-2 (DC101) was capable of inhibiting angiogenesis (79 reduction in PECAM + blood vessels) and growth (93 reduction in tumor volume). However, unlike an anti-VEGFR-3 Mab (mF4-31C1), DC101 was not capable of eliminating either tumor lymphangiogenesis or lymphogenous metastasis (60 reduction of lymph node metastasis by DC101 vs 95 by mF4-31C1). Early excision of the primary tumors demonstrated that VEGF-D-mediated tumor spread precedes angiogenesis-induced growth. Small but highly metastatic primary human breast cancers had significantly higher lymphatic vessel density (23.1 vessels/mm(2)) than size-matched (11.7) or larger non-metastatic tumors (12.4) thus supporting the importance of lymphatic vessels, as opposed to angiogenesis-mediated primary tumor growth, for nodal metastasis. These results suggest that lymphangiogenesis via VEGF-D is more critical than angiogenesis for nodal metastasis.
Original languageEnglish
Pages (from-to)819 - 832
Number of pages14
JournalClinical and Experimental Metastasis
Volume30
DOIs
Publication statusPublished - 2013
Externally publishedYes

Cite this

Matsumoto, M., Roufail, S., Inder, R., Caesar, C., Karnezis, T., Shayan, R., Farnsworth, R. H., Sato, T., Achen, M. G., Mann, G. B., & Stacker, S. A. (2013). Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis. Clinical and Experimental Metastasis, 30, 819 - 832. https://doi.org/10.1007/s10585-013-9581-x